PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
2.71
P/E 50-75% of CRN.AX's 5.32. Mohnish Pabrai would examine if this pricing gap presents opportunity.
2.44
P/S above 1.5x CRN.AX's 1.43. Michael Burry would check for mean reversion risks.
1.98
P/B above 1.5x CRN.AX's 0.78. Michael Burry would check for potential asset overvaluation.
-29.62
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.
-86.08
Negative operating cash flow while CRN.AX shows P/OCF of 14.81. Joel Greenblatt would examine operational improvement potential.
1.93
Fair value ratio above 1.5x CRN.AX's 0.78. Michael Burry would check for mean reversion risks.
9.21%
Earnings yield exceeding 1.5x CRN.AX's 4.70%. David Dodd would verify if earnings quality justifies this premium.
-3.30%
Both companies show negative FCF. Martin Whitman would check for industry-wide capital intensity issues.